首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >A randomised controlled trial assessing the use of citalopram sertraline fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial
【2h】

A randomised controlled trial assessing the use of citalopram sertraline fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial

机译:评估使用西酞普兰舍曲林氟西汀和米氮平预防长期维持抗抑郁药的初级保健患者复发的随机对照试验(ANTLER:抗抑郁药以防止dEpRession缓解):一项随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAntidepressants are used both for treating acute episodes and for prophylaxis to prevent future episodes of depression, also called maintenance treatment. This article describes the protocol for a randomised controlled trial (ANTLER: ANTidepressants to prevent reLapse in dEpRession) to investigate the clinical effectiveness and cost-effectiveness in UK primary care of continuing on long-term maintenance antidepressants compared with a placebo in preventing relapse of depression in those who have taken antidepressants for more than 9 months and who are currently well enough to consider stopping maintenance treatment.
机译:背景技术抗抑郁药既可用于治疗急性发作,也可用于预防预防未来的抑郁发作,也称为维持治疗。本文介绍了一项随机对照试验的方案(ANTLER:抗抑郁药可防止dEpRession中的复发),以调查在英国初级保健中长期维持抗抑郁药与安慰剂相比在预防抑郁症复发方面的临床疗效和成本效益。在服用抗抑郁药超过9个月且目前已经足够考虑停止维持治疗的患者中。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号